Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years

By sjmartinez • January 6, 2024

Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, Vencovský J, Wilson AG, Burmester GR, Coombs D, Penn SK, Khan N, Yee JB, Rahawi K, McInnes IB. Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatol Ther. 2024 Jan 5. doi: 10.1007/s40744-023-00624-3. Epub ahead of print. PMID: 38180720.

Tags: JAK inhibitor, Laboratory parameters, Publications, Rheumatoid arthritis, Rheumatology, Upadacitinib

Structure, identification and characterization of the RibD-enolase complex in Francisella

Liu X, Clemens DL, Lee BY, Aguirre R, Horwitz MA, Zhou ZH. Structure, identification and characterization of the RibD-enolase complex in Francisella. Protein Cell. 2025[...]

Cardiac Implantable Device Infection Surveillance Algorithm

Mull HJ, Golenbock SW, Basnet Thapa D, Shin MH, Harvey KL, Lamkin RP, Strymish J, Branch-Elliman W. Cardiac Implantable Device Infection Surveillance Algorithm. JAMA Netw[...]

Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study

Wang FM, Ballew SH, Folsom AR, Wagenknecht LE, Howard CM, Coresh J, Budoff MJ, Blaha MJ, Matsushita K. Mid- to Late-Life Traditional Cardiovascular Risk Factor[...]